- Allergies22 products
- Anti Fungal22 products
- Anti Viral55 products
- Antibiotics1515 products
- Anxiety22 products
- Arthritis33 products
- Asthma44 products
- Blood Pressure44 products
- Cholesterol Lowering22 products
- Depression88 products
- Diabetes33 products
- Erectile Dysfunction44 products
- Gastrointestinal99 products
- Hair Loss11 product
- Heart Disease33 products
- Men's Health44 products
- Muscle Relaxant22 products
- Other1616 products
- Pain Relief88 products
- Quit Smoking22 products
- Skincare88 products
- Sleep Aid33 products
- Weight Loss22 products
- Woman's Health1616 products
Pharm News
- The FDA has given fast track status to Pyxis’ drug, PYX-201. This means the approval process for PYX-201 will be sped up because it shows promise in treating a serious condition. However, the text does not mention any specific pill names related to PYX-201.
- Regeneron is trying again to get approval for its blood cancer treatment. If possible, please include the names of some medications in the explanation.
- How pharmaceutical companies can use print materials to stay flexible and competitive.
- Astellas, a pharmaceutical company, disagrees with European authorities about their drug, Izervay, which is used to treat a condition called geographic atrophy.
- “5 Important FDA Decisions to Look Out for in the Last Quarter of the Year”
